OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for September, 2012

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2012-09-30 12:00 Pfizer Lung Cancer Drug Doubles Benefit, Researchers Say and more... 2012-09-30 00:00 Teva acquires Huntexil development programme rights from NeuroSearch and more... 2012-09-29 00:00 Novo Nordisk halts development of hemophilia drug and more... 2012-09-28 12:00 Watson Pharma selling $3.75B in senior notes to help fund Actavis deal and more... 2012-09-28 00:00 Abbott misstated credentials of spinoff CEO Gonzalez and more... 2012-09-27 12:00 Reckitt's Decision Opens The Door For Titan Pharma And BioDelivery Sciences and more... 2012-09-27 00:00 FDA to decide by March on Pfizer/Bristol blood thinner and more... 2012-09-26 12:00 Mallinckrodt acquiring CNS Therapeutics for $100 million in cash and more... 2012-09-26 00:00 Another Approval for Amgen's Prolia and more... 2012-09-25 12:00 Cosmo Pharma CEO Sees $1.5 Billion Dye Luring Buyer by 2013 and more... 2012-09-25 00:00 In The Wake Of An FDA Probe, It's Time Questcor Shareholders Begin To Consider Alternatives and more... 2012-09-24 12:00 Peregrine Pharma Stock Craters on Lung Cancer Drug Blowup and more... 2012-09-24 00:00 R&D and launch of new generic drugs to up US biz: Wockhardt and more... 2012-09-23 00:00 US FDA approves Acton Pharma's Aerospan to treat asthma and more... 2012-09-22 00:00 Report: Roche's Zelboraf, BMS' Yervoy control their segment and more... 2012-09-21 12:00 MorphoSys Chief Says MOR103 Drug Data Makes Deal More Likely and more... 2012-09-21 00:00 FDA: Boehringer Parkinson's med may boost heart failure risk and more... 2012-09-20 12:00 Neuralstem Reminds Investors Of Stem Cell Rewards And Risk and more... 2012-09-19 12:00 Why Jazz Pharmaceuticals Could Head Even Higher 2012-09-19 00:00 Isis: A Biotechnology Firm Making Its First Step Towards Profitability? and more... 2012-09-18 12:00 PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth and more... 2012-09-18 00:00 Vical and Bristol-Myers Ink Deal and more... 2012-09-17 12:00 Targacept says trial for ADHDi drug did not meet primary outcome measure and more... 2012-09-17 00:00 Sirtex Deal Elevated With Liver Cancer Therapy: Real M&A and more... 2012-09-16 00:00 Pfizer expanding force in China and more... 2012-09-15 12:00 GlaxoSmithKline takes stake in Response Genetics and more... 2012-09-15 00:00 Gilead Sciences Makes Headlines With HIV Prevention Pill, Looks to Hepatitis Drugs for Future and more... 2012-09-14 12:00 Is Dynavax an Underdog -- or Just a Dog? and more... 2012-09-14 00:00 Cornerstone Therapeutics says FDA advisers recommend against approving its drug lixivaptan and more... 2012-09-13 12:00 Seven reasons to buy DUSA Pharmaceuticals and more... 2012-09-13 00:00 FDA Approves GenzymeâÔö£é?öé??Ôö£é?ö?ñós AUBAGIO?ë?£Ôö£éÔö¼?½ (teriflunomide), a Once-Daily, Oral Treatment for Relapsing Multiple Sclerosis and more... 2012-09-12 00:00 Cell Therapeutics soars 24% on EU drug launch and more... 2012-09-11 12:00 "Better Than Nothing" Doesn't Cut It for Zalicus and more... 2012-09-11 00:00 3 Things to Watch With Arena Pharmaceuticals and more... 2012-09-10 12:00 AstraZeneca halts development of anti-obesity drug and more... 2012-09-09 12:00 Teva sues Perrigo over ProAir asthma inhaler patents and more... 2012-09-08 12:00 Abbott inks pact with Astellas Pharma in Phase 3 clinical trial for ASP0113 and more... 2012-09-08 00:00 Roche expects to keep Rituxan monopoly until 2015 and more... 2012-09-07 12:00 Another Weight Loss Drug Gets Props from Wall Street and more... 2012-09-07 00:00 Mylan Waits Patiently at the Bottom of the Patent Cliff and more... 2012-09-06 12:00 FDA OKs Cancer Drugs Faster Than Other Meds and more... 2012-09-06 00:00 High-End HIV Drug Stribild To Set Gilead Sciences Apart and more... 2012-09-05 12:00 Roche Vows To Keep Up R&D Spend, Go Beyond Cancer Therapies and more... 2012-09-05 00:00 Sanofi signals Lemtrada confidence with CVR buyback and more... 2012-09-04 12:00 Sarepta Therapeutics: Stock Rising Too Far, Too Fast? and more... 2012-09-01 00:00 Game Changer for the Human Genome Sector? and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe